marketing agreement

Promega's technology will be part of a larger portfolio of research products aimed at supporting oncology drug and clinical trial development.

AmCare Genomics said that it has a large network that would enable it to raise awareness about Genomic Vision's test for facioscapulohumeral muscular dystrophy. 

Thermo Fisher will sell Synthego's synthetic guide RNA products under the Invitrogen TrueGuide brand. 

Under the partnership, DNAnexus customers will have direct access to the Dragen Genome Pipeline for "ultra-rapid" genome analysis.

The agreement, which covers Interpace's ThyGenX and ThyraMIR diagnostic tests for the diagnosis of thyroid cancer in patients with indeterminate thyroid nodules.

Zogen will market and promote OncoDNA's genomic testing and data interpretation services to oncologists in Mexico.

Under the terms of the deal, HDB will have access to Luxcel's assays and technologies for mitochondrial function, metabolism, and toxicity.

LifeCodexx's PrenaTest will be available to women in Malaysia, Singapore, Thailand, Brunei, Vietnam, the United Arab Emirates, and elsewhere in the Middle East.